Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Published October 22, 2025 · Recall initiated: October 8, 2025
Summary
FDA records drug Class II recall D-0028-2026, published October 22, 2025 and initiated October 8, 2025. Recalling firm: ASTRAZENECA PHARMACEUTICALS; Status: Ongoing; Reported quantity: 916 pre-filled syringes; Lot: Lot YJ0152, Expiry: 01/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility:
What to do
Voluntary: Firm initiated · E-Mail
Get an email if FASENRA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FASENRA
- Manufacturer
- ASTRAZENECA PHARMACEUTICALS
- Distributor
- Nationwide in the U.S
- Lot
- Lot YJ0152, Expiry: 01/31/2028.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging,October 22, 2025
- FDACarbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for:October 22, 2025
- FDAEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,October 22, 2025
- FDAHaifa COLD SMOKED SALMON 8 OZ.October 22, 2025
- FDAFentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc.,October 22, 2025
- FDANOW Real Food Organic Unsalted Whole Raw Cashews, 10 oz. pouch, UPC 7 33739 07066 1 Product Code 7066October 22, 2025
Questions about this recall
Was Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30 recalled?
Yes. FDA published recall D-0028-2026 on October 22, 2025. Reported hazard: Lack of Assurance of Sterility:
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FASENRA.